NovaBridge Biosciences Price/Book Ratio
The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.
- NovaBridge Biosciences price/book ratio for the quarter ending 2025-12-31 was 4.57, a 476.68% increase year-over-year.
- NovaBridge Biosciences price/book ratio for the quarter ending 2025-09-30 was 3.87.
- NovaBridge Biosciences price/book ratio for the quarter ending 2025-06-30 was 2.31.
- NovaBridge Biosciences price/book ratio for the quarter ending 2024-12-31 was 0.79, a 45.52% decline year-over-year.
- NovaBridge Biosciences price/book ratio for fiscal 2025 was 4.57, a 476.68% increase from fiscal 2024.
- NovaBridge Biosciences price/book ratio for fiscal 2024 was 0.79, a 45.52% decline from fiscal 2023.
- NovaBridge Biosciences price/book ratio for fiscal 2023 was 1.45, a 23.87% decline from fiscal 2022.
- NovaBridge Biosciences price/book ratio for fiscal 2022 was 1.91, a 84.32% decline from fiscal 2021.
- Available history
- 2020-09-30 to 2025-12-31
- Data captured